FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Ifosfamide Injection
Status: Currently in Shortage
»Date first posted: 06/12/2026
»Therapeutic Categories: Oncology; Pediatric

Expand all

Baxter Healthcare (Reverified 08/07/2026)

Company Contact Information:
888-229-0001

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Ifosfamide, Injection, 1 g/20 mL (NDC 10019-925-01)	Unavailable	Estimated recovery: September 2026	Requirements related to complying with good manufacturing practices
Ifosfamide, Injection, 3 g/60 mL (NDC 10019-926-02)	Unavailable	Estimated recovery: October 2026	Requirements related to complying with good manufacturing practices
IFEX, Injection, 1 g/20 mL (NDC 0338-3991-01)	Unavailable	Estimated recovery: October 2026	Requirements related to complying with good manufacturing practices
IFEX, Injection, 3 g/60 mL (NDC 0338-3993-01)	Unavailable	Estimated recovery: October 2026	Requirements related to complying with good manufacturing practices

Fresenius Kabi USA, LLC (Reverified 08/04/2026)

Company Contact Information:
888-386-1300

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Ifosfamide, Injection, 1 g (NDC 63323-142-10)	Unavailable	Next release August 2026	Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (Reverified 08/07/2026)

Company Contact Information:
800-631-2174

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9531-01)	Available	Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.
Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9530-01)	Unavailable	Product will be made available as it is released.	Demand increase for the drug